TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
BHP Shares Fall as Jansen Potash Project Costs Surge 
 Applauds Gov. Brown on Budget that Invests $10 Million in Precision Medicine Research - EconoTimes)
SOUTH SAN FRANCISCO & SAN DIEGO, Jan. 8, 2016 (GLOBE NEWSWIRE) -- The California Life Sciences Association (CLSA) today issued the following statement from CLSA President & CEO Sara Radcliffe applauding Gov. Jerry Brown's 2016 – 2017 budget proposal that includes $10 million for precision medicine research. CLSA is the leading voice to drive innovation for California's life sciences sector, serving over 750 life sciences organizations across California.
"California Life Sciences Association (CLSA) applauds Governor Jerry Brown and his Administration for their unwavering support of life sciences innovation, as demonstrated again in this year's budget which calls for a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the state's life sciences sector employs over 281,000 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients.
"We look forward to working with the Governor to best invest these research dollars to better understand and combat disease in the 21st century. Many CLSA member companies, universities and research institutes are already working in the precision medicine space and we applaud Governor Brown for his thoughtful and visionary support to advance this important research here in California."
Click here to view the budget proposal.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
CONTACT: Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848
